Literature DB >> 9399528

Direct detection of Mycobacterium tuberculosis complex in clinical samples from patients in Norway by ligase chain reaction.

A Lindbråthen1, P Gaustad, B Hovig, T Tønjum.   

Abstract

Our aim was to investigate the use of DNA amplification with the ligase chain reaction (LCR) for detection of the Mycobacterium tuberculosis complex directly in human clinical specimens. The LCR assay employed was the Abbott LCx MTB Assay, which uses the gene encoding protein antigen b as the target template. Four hundred eighty-two samples from 457 patients in one clinical microbiology laboratory in Norway were processed by routine culture analysis (BACTEC culture), direct microscopy (Ziehl-Neelsen staining) and LCR. Of the 118 specimens containing cultivable M. tuberculosis, 106 (90.6%) were detected by LCR. Among the 364 culture-negative specimens, 356 samples were negative also by LCR and 8 (1.6%) were positive by LCR. In five of the eight LCR-positive and culture-negative samples, another sample from the same patient was M. tuberculosis culture positive and/or the patient had symptoms of tuberculosis. In comparison with culture, the sensitivity of LCR was 96.7% for smear-positive samples and 72.0% for smear-negative samples, respectively. For all samples combined, the sensitivity, specificity, and positive and negative predictive values were 90.2, 99.2, 97.4, and 96.7%, respectively. Challenging the M. tuberculosis LCR test with DNAs and cultures from strains of Mycobacterium ulcerans and Mycobacterium marinum, which are the mycobacterial species most closely related to the M. tuberculosis complex, resulted in all-negative test results. The sensitivity, specificity, and positive and negative predictive values of BACTEC culture in comparison with the LCR test and clinical criteria were 95.9, 100, 100, and 98.6%, respectively. A certain prioritization of samples subjected to the LCR assay should be based on clinical indications and risks with regard to infection transmission and patient isolation policy. More automation and lower expenses are generally desired for nucleic acid amplification kits. However, this M. tuberculosis LCR assay represents a valuable tool in routine mycobacterial diagnostics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399528      PMCID: PMC230156          DOI: 10.1128/jcm.35.12.3248-3253.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria.

Authors:  G P KUBICA; W E DYE; M L COHN; G MIDDLEBROOK
Journal:  Am Rev Respir Dis       Date:  1963-05

Review 2.  Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species.

Authors:  V V Lévy-Frébault; F Portaels
Journal:  Int J Syst Bacteriol       Date:  1992-04

3.  Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples.

Authors:  A Brisson-Noël; B Gicquel; D Lecossier; V Lévy-Frébault; X Nassif; A J Hance
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

4.  Analytic performance and contamination control methods of a ligase chain reaction DNA amplification assay for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  H Y Hu; J D Burczak; G W Leckie; K A Ray; S Muldoon; H H Lee
Journal:  Diagn Microbiol Infect Dis       Date:  1996-02       Impact factor: 2.803

5.  Multiplex strand displacement amplification (SDA) and detection of DNA sequences from Mycobacterium tuberculosis and other mycobacteria.

Authors:  G T Walker; J G Nadeau; P A Spears; J L Schram; C M Nycz; D D Shank
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

6.  Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

Authors:  G Middlebrook; Z Reggiardo; W D Tigertt
Journal:  Am Rev Respir Dis       Date:  1977-06

7.  Comparison of manual Amplicor PCR, Cobas Amplicor PCR, and LCx assays for detection of Chlamydia trachomatis infection in women by using urine specimens.

Authors:  R Pasternack; P Vuorinen; T Pitkäjärvi; M Koskela; A Miettinen
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

8.  Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis.

Authors:  A B Andersen; E B Hansen
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

9.  Amplification of residual DNA sequences in sterile bronchoscopes leading to false-positive PCR results.

Authors:  K Kaul; S Luke; C McGurn; N Snowden; C Monti; W A Fry
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes.

Authors:  K D Evans; A S Nakasone; P A Sutherland; L M de la Maza; E M Peterson
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more
  12 in total

1.  Evaluation of three commercial detection systems for Mycobacterium tuberculosis where clinical diagnosis is difficult.

Authors:  T J Brown; E G Power; G L French
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

2.  Rapid diagnosis of pulmonary tuberculosis with the LCx Mycobacterium tuberculosis assay and comparison with conventional diagnostic techniques.

Authors:  P Rohner; E I Jahn; B Ninet; C Ionati; R Weber; R Auckenthaler; G E Pfyffer
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis.

Authors:  T Tønjum; D B Welty; E Jantzen; P L Small
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Failure of commercial ligase chain reaction to detect Mycobacterium tuberculosis DNA in sputum samples from a patient with smear-positive pulmonary tuberculosis due to a deletion of the target region.

Authors:  Christopher M Gilpin; David J Dawson; Gabrielle O'Kane; John G Armstrong; Christopher Coulter
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Multicenter evaluation of the Abbott LCx Mycobacterium tuberculosis ligase chain reaction assay.

Authors:  R Lumb; K Davies; D Dawson; R Gibb; T Gottlieb; C Kershaw; K Kociuba; G Nimmo; N Sangster; M Worthington; I Bastian
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

6.  Rapid-cycle PCR and fluorimetry for detection of mycobacteria.

Authors:  Jacqueline Lachnik; Birgit Ackermann; Antje Bohrssen; Silvia Maass; Catharina Diephaus; Axel Puncken; Marion Stermann; Franz-Christoph Bange
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Performance characteristics of the BDProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens.

Authors:  G E Pfyffer; P Funke-Kissling; E Rundler; R Weber
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

8.  Evaluation of the Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in human samples.

Authors:  M G Garrino; Y Glupczynski; J Degraux; H Nizet; M Delmée
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 9.  Molecular diagnostics in tuberculosis: basis and implications for therapy.

Authors:  Seetha V Balasingham; Tonje Davidsen; Irena Szpinda; Stephan A Frye; Tone Tønjum
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

10.  Comparative evaluation of the new gen-probe Mycobacterium tuberculosis amplified direct test and the semiautomated abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens.

Authors:  C Piersimoni; A Callegaro; C Scarparo; V Penati; D Nista; S Bornigia; C Lacchini; M Scagnelli; G Santini; G De Sio
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.